Symposium 01 : Nov. 16 (Thu),09:00-10:20
- Distinguished research of 2023 in liver disease

• Viral hepatitis Beom Kyung Kim
  Yonsei University, Korea CV 즐겨찾기
• Alcoholic and nonalcoholic liver disease Hwi Young Kim
  Ewha Womans University, Korea CV 즐겨찾기
• Liver cirrhosis and complications Jeong Han Kim
  Konkuk University, Korea CV 즐겨찾기
• Hepatocellular carcinoma Ju Hyun Shim
  University of Ulsan, Korea CV 즐겨찾기

Special Lecture : Nov. 16 (Thu),11:00-11:30
- Chung Yong Kim Memorial Lecture & General Meeting

• Hepatic Fibrogenesis: From bench to bed? Kwan Sik Lee
  CHA University, Korea CV 즐겨찾기

Symposium 14 : Nov. 16 (Thu),13:30-14:50
- Liver organoids and their applications for human liver diseases

• Use of liver-on-a-chip for preclinical drug development and cell therapy Tae-Eun Park
  Ulsan National Institute of Science and Technology (UNIST), Korea CV 즐겨찾기
• Human pluripotent stem cell-derived liver organoids: from fabrication to application Myung Jin Son
  Korea Research Institute of Bioscience and Biotechnology (KRIBB), Korea CV 즐겨찾기
• Establishment of liver cancer organoids for enhanced treatment decision-making Jun Yong Park
  Yonsei University, Korea CV 즐겨찾기
• Applications of human iPSCs-derived organoids in practice: present and future perspectives Yong Kyun Kim
  The Catholic University of Korea, Korea CV 즐겨찾기

Symposium 16 : Nov. 16 (Thu),15:10-16:30
- Efforts to achieve functional cure for chronic hepatitis B (CHB)

• Impact of HBsAg seroclearance in the long-term outcomes of CHB Hyun Yang
  The Catholic University of Korea, Korea CV 즐겨찾기
• Can finite NUC strategy increase the functional cure of CHB? Ju-Yeon Cho
  Chosun University, Korea CV 즐겨찾기
• Available biomarkers to predict functional cure Jihyun An
  Hanyang University, Korea CV 즐겨찾기
• Promising new treatment for functional cure Gwang Hyeon Choi
  Seoul National University, Korea CV 즐겨찾기

Symposium 22 : Nov. 17 (Fri),09:00-10:20
- Emerging issue on nonalcoholic fatty liver disease (NAFLD)

• Metabolic drugs in patients with NAFLD and diabetes: pioglitazone, GLP-1 agonist, and SGLT2 inhibitor Soon Sun Kim
  Ajou University, Korea CV 즐겨찾기
• Metabolic and genetic risk factors for NAFLD George Boon-Bee Goh
  Singapore General Hospital, Singapore CV 즐겨찾기
• Inter-organ crosstalk in the pathogenesis of NAFLD Dae Won Jun
  Hanyang University, Korea CV 즐겨찾기
• Risk factors and prognosis of NAFLD-related hepatocellular carcinoma Sang Bong Ahn
  Eulji University, Korea CV 즐겨찾기

Symposium 26 : Nov. 17 (Fri),10:40-12:00
- Recent updates of cellular mechanisms and antifibrotic therapy in liver fibrosis

• Mechanisms of fibrosis progression: factors activating intrahepatic macrophages Hyuk Soo Eun
  Chungnam National University, Korea CV 즐겨찾기
• Crosstalk between stellate cells and immune cells in liver fibrosis Young-Sun Lee
  Korea University, Korea CV 즐겨찾기
• Roles of sinusoidal endothelial cells in liver fibrosis and portal hypertension Moon Young Kim
  Yonsei University Wonju, Korea CV 즐겨찾기
• Therapeutic advances in anti-fibrosis therapy in chronic liver diseases Seung Kak Shin
  Gachon University, Korea CV 즐겨찾기

Symposium 29 : Nov. 17 (Fri),13:30-14:50
- Key questions on the management of hepatocellular carcinoma

• HCC surveillance for non-cirrhotic patients: the target population and surveillance tool Do Young Kim
  Yonsei University, Korea CV 즐겨찾기
• Selection of curative options for oligometastasis from HCC Wonseok Kang
  Sungkyunkwan University, Korea 즐겨찾기
• Early switch to or frontline systemic therapy for intermediate stage HCC Yuri Cho
  National Cancer Center, Korea CV 즐겨찾기
• Biomarker-based precision care of systemic therapy in HCC Stephen Chan
  The Chinese University of Hong Kong, Hong Kong CV 즐겨찾기

Symposium 32 : Nov. 17 (Fri),15:10-16:30
- Controversial issue on liver disease

• Benign liver tumors: which to perform surgical resection and follow-up care? Jeong-Ju Yoo
  Soonchunhyang University, Korea CV 즐겨찾기
• When to test for hepatitis D virus and how to treat it? Young Eun Chon
  CHA University, Korea 즐겨찾기
• Ongoing issues in chronic hepatitis C: use of DAAs in HCC, reinfection, and surveillance after SVR Young Youn Cho
  Chung-Ang University, Korea CV 즐겨찾기
• Prevention and management of gastrointestinal bleeding during atezolizumab-bevacizumab for HCC Hee Yeon Kim
  The Catholic University of Korea, Korea CV 즐겨찾기

USG01 : Nov. 18 (Sat),09:00-10:30
- Abdominal US training specialist 1

• Useful tips to set up ultrasound rooms Moon Young Kim
  Yonsei University Wonju, Korea CV 즐겨찾기
• Ultrasound education for residents and fellows Seong Hee Kang
  Korea University, Korea CV 즐겨찾기
• How to write an abdominal ultrasound report Mi Na Kim
  Yonsei University, Korea CV 즐겨찾기
• How to perform liver biopsy Yu Rim Lee
  Kyungpook National University, Korea CV 즐겨찾기

USG02 : Nov. 18 (Sat),10:30-12:00
- Abdominal US training specialist 2

• Application of doppler ultrasound in liver disease Jeong Eun Song
  Daegu Catholic University, Korea CV 즐겨찾기
• Application of microvascular imaging in hepatobiliary disease Jae Young Lee
  Seoul National University, Korea 즐겨찾기
• US guided procedures using various localization methods Dong Ho Lee
  Seoul National University, Korea CV 즐겨찾기
• Fibroscan and shear wave elastography Jeong-Ju Yoo
  Soonchunhyang University, Korea CV 즐겨찾기